BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8112436)

  • 1. Heterogeneity of type III procollagen N-terminal peptides in BAL fluid from normal and fibrotic lungs.
    Harrison NK; McAnulty RJ; Kimpton WG; Fraser JR; Laurent TC; Laurent GJ
    Eur Respir J; 1993 Nov; 6(10):1443-8. PubMed ID: 8112436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type III and type I procollagen markers in fibrosing alveolitis.
    Lammi L; Ryhänen L; Lakari E; Risteli J; Pääkkö P; Kahlos K; Lähde S; Kinnula V
    Am J Respir Crit Care Med; 1999 Mar; 159(3):818-23. PubMed ID: 10051256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical, physiologic, and clinical validation of a radioimmunoassay for measurement of procollagen type III amino terminal propeptide in serum and bronchoalveolar lavage fluid obtained from dogs.
    Schuller S; Valentin S; Remy B; Jespers P; Foulon S; Van Israël N; Clercx C; McEntee K
    Am J Vet Res; 2006 May; 67(5):749-55. PubMed ID: 16649905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procollagen type III amino terminal propeptide concentrations in dogs with idiopathic pulmonary fibrosis compared with chronic bronchitis and eosinophilic bronchopneumopathy.
    Heikkilä HP; Krafft E; Jespers P; McEntee K; Rajamäki MM; Clercx C
    Vet J; 2013 Apr; 196(1):52-6. PubMed ID: 22909956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased procollagen III aminoterminal peptide-related antigens and fibroblast growth signals in the lungs of patients with idiopathic pulmonary fibrosis.
    Cantin AM; Boileau R; Bégin R
    Am Rev Respir Dis; 1988 Mar; 137(3):572-8. PubMed ID: 3345038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyaluronan and procollagen type III aminoterminal peptide in serum and bronchoalveolar lavage fluid from patients with pulmonary fibrosis.
    Milman N; Kristensen MS; Bentsen K
    APMIS; 1995 Oct; 103(10):749-54. PubMed ID: 8534435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propeptide levels of type III and type I procollagen in the serum and bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis.
    Lammi L; Kinnula V; Lähde S; Risteli J; Pääkkö P; Lakari E; Ryhänen L
    Eur Respir J; 1997 Dec; 10(12):2725-30. PubMed ID: 9493651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous measurement of collagen type-VI-related antigen and procollagen type-III-N-propeptide levels in bronchoalveolar lavage.
    Schaberg T; Orzechowski K; Oesterling C; Lode H; Schuppan D
    Eur Respir J; 1994 Jul; 7(7):1221-6. PubMed ID: 7925898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum and bronchoalveolar lavage of N-terminal type III procollagen peptides in idiopathic pulmonary fibrosis.
    Low RB; Giancola MS; King TE; Chapitis J; Vacek P; Davis GS
    Am Rev Respir Dis; 1992 Sep; 146(3):701-6. PubMed ID: 1519851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation of lymphocytes and PIIINP with the combined pulmonary fibrosis and emphysema].
    Wei XH; Wu XY; Wang JH; Thakur A; Ma AQ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jul; 26(7):675-8. PubMed ID: 20619092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Type III procollagen N-terminal peptide and type IV collagen-7S level in the serum and BALF of patients with non-Hodgkin's lymphoma before and after chemotherapy].
    Niitsu N; Umeda M
    Rinsho Ketsueki; 1994 Nov; 35(11):1267-75. PubMed ID: 7529840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Type III procollagen N-terminal peptide (P-III-P, prolyl hydroxylase (PH), and laminin P1 levels in serum and BALF of radiotherapy patients].
    Matsumoto S; Shindo J; Horiba M; Hara M; Inoue K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Jan; 30(1):28-34. PubMed ID: 1320708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronan and procollagen type III aminoterminal peptide in serum and bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis.
    Milman N; Kristensen MS; Bentsen K; Grode G; Frederiksen J
    Sarcoidosis; 1995 Mar; 12(1):38-41. PubMed ID: 7617974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type III procollagen N-terminal peptides in experimental pulmonary fibrosis and human respiratory diseases.
    Watanabe Y; Yamaki K; Yamakawa I; Takagi K; Satake T
    Eur J Respir Dis; 1985 Jul; 67(1):10-6. PubMed ID: 2414122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carboxyterminal propeptide of type I procollagen in ELF: elevation in asbestosis, but not in pleural plaque disease.
    Lammi L; Ryhänen L; Lakari E; Risteli J; Pääkkö P; Ruotsalainen EM; Lähde S; Kinnula VL
    Eur Respir J; 1999 Sep; 14(3):560-4. PubMed ID: 10543275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lavage type III procollagen N-terminal peptides in human pulmonary fibrosis and sarcoidosis.
    Low RB; Cutroneo KR; Davis GS; Giancola MS
    Lab Invest; 1983 Jun; 48(6):755-9. PubMed ID: 6855198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Four markers of collagen metabolism as possible indicators of disease in the adult respiratory distress syndrome.
    Farjanel J; Hartmann DJ; Guidet B; Luquel L; Offenstadt G
    Am Rev Respir Dis; 1993 May; 147(5):1091-9. PubMed ID: 8484615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of elevated procollagen-III-peptide and transforming growth factor-beta levels of bronchoalveolar lavage fluids from idiopathic pulmonary fibrosis patients.
    Hiwatari N; Shimura S; Yamauchi K; Nara M; Hida W; Shirato K
    Tohoku J Exp Med; 1997 Feb; 181(2):285-95. PubMed ID: 9163845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Determination of procollagen III levels in serum and broncho-alveolar lavage fluid in patients with interstitial lung disease and its clinical significance].
    Chen B; Zhao H; Lu C
    Zhonghua Nei Ke Za Zhi; 1995 May; 34(5):312-4. PubMed ID: 8565714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
    Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.